New Blood Test May Predict Alzheimer’s Disease Risk

Overview of an Alzheimer’s Disease Blood Test

Dr. Jeremy Koppel provides insights into a groundbreaking blood test for Alzheimer’s disease, explaining its method of identifying abnormal protein accumulation. This test is currently used to diagnose individuals showing symptoms.

Signs of Early-Onset Alzheimer’s

Recent research from Finland suggests certain medical conditions could indicate early-onset Alzheimer’s disease several years before an official diagnosis. The study points to conditions like depression, vertigo, headaches, and more as potential early indicators.

Researchers found increased occurrence of these conditions in the five years preceding an Alzheimer’s diagnosis.

Study Findings

Researchers analyzed records of 407 individuals with early-onset Alzheimer’s and 4,035 others of similar age and sex without the diagnosis, focusing on the medical records 15 years prior to diagnosis. These conditions were more prevalent in those diagnosed:

• Vertigo: 5.9% diagnosed, 2.1% not diagnosed
• Depression: 5.7% diagnosed, 2.3% not diagnosed
• Headache: 4.9% diagnosed, 1.6% not diagnosed
• Stroke: 4.4% diagnosed, 2.0% not diagnosed
• Alcohol-related disorders: 3.4% diagnosed, 1.4% not diagnosed
• Brain disorders: 2.9% diagnosed, 0.9% not diagnosed
• Thyroid disorders: 2.5% diagnosed, 0.8% not diagnosed
• Epilepsy: 2.2% diagnosed, 0.7% not diagnosed
• Delirium: 1.5% diagnosed, 0.1% not diagnosed
• Ear, nose, and throat disorders: 5.2% diagnosed, 2.9% not diagnosed

The differences in these medical conditions became more evident within the five years before an early-onset Alzheimer’s diagnosis.

Healthcare Visits and Emerging Symptoms

The study indicated a substantial increase in healthcare visits among early-onset Alzheimer’s patients around the time of diagnosis, potentially signaling emerging symptoms.

Study Limitations

The study’s observational nature means it establishes associations but cannot definitively demonstrate predictive reliability. Dr. Suvi-Johanna Krüger emphasized in a press release that neuropathological changes precede clinical symptoms by 15 to 20 years.

While previous research has focused mostly on late-onset Alzheimer’s, less is known about early-onset cases.
Larger future studies exploring biomarkers, genetics, and clinical assessments could clarify causal relationships between these medical conditions and Alzheimer’s incidence.

Importance of Early Diagnosis

Early diagnosis allows more treatment and support options. It also provides individuals and families ample time to plan and access support services.
Individuals experiencing persistent medical symptoms should consult healthcare providers for proper assessment.